21 related articles for article (PubMed ID: 21083509)
1. Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.
Di Florio A; Sancho V; Moreno P; Delle Fave G; Jensen RT
Biochim Biophys Acta; 2013 Mar; 1833(3):573-82. PubMed ID: 23220008
[TBL] [Abstract][Full Text] [Related]
2. Investigation of cancer cell lines for peptide receptor-targeted drug development.
Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
Moody TW; Sun LC; Mantey SA; Pradhan T; Mackey LV; Gonzales N; Fuselier JA; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2006 Sep; 318(3):1265-72. PubMed ID: 16766720
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
[TBL] [Abstract][Full Text] [Related]
5. Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells.
Moody TW; Mantey SA; Pradhan TK; Schumann M; Nakagawa T; Martinez A; Fuselier J; Coy DH; Jensen RT
J Biol Chem; 2004 May; 279(22):23580-9. PubMed ID: 15016826
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the study of small peptides in targeted drug delivery system].
Sun Y; Wang C
Yao Xue Xue Bao; 2008 Oct; 43(10):992-6. PubMed ID: 19127861
[TBL] [Abstract][Full Text] [Related]
7. Peptides as carrier for tumor diagnosis and treatment.
Langer M; Beck-Sickinger AG
Curr Med Chem Anticancer Agents; 2001 May; 1(1):71-93. PubMed ID: 12678771
[TBL] [Abstract][Full Text] [Related]
8. Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
Sun L; Morris LM; Luo J; Mackey LV; Leslie JS; Franko-Tobin LG; Fuselier JA; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):666-74. PubMed ID: 21083509
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor-targeted anti-cancer therapy.
Sun LC; Coy DH
Curr Drug Deliv; 2011 Jan; 8(1):2-10. PubMed ID: 21034425
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
